Lisa Harding, MD, urges psychiatrists to gather histories, deprescribe safely, and send focused sleep referrals now that orexin agonists have arrived for narcolepsy.
Commentary|Articles|December 9, 2024
ACNP Meeting Highlights Bright Future for Psychiatry
Author(s)Steven P. Levine, MD, Heidi Anne Duerr, MPH
In highlighting recent advances and fostering collaboration and networking, the ACNP Annual Meeting helps usher in 2025 with hope and positivity.
Advertisement
CONFERENCE REPORTER
Psychiatric Times sat down with Steve Levine, MD, psychiatrist and senior vice president of Patient Access and Medical Affairs at Compass Pathways to discuss the 63rd Annual Meeting of the American College of Neuropsychopharmacology, the latest advances in psychiatry, and the reasons the field can be hopeful as we look toward 2025.
Did you attend the ACNP Annual Meeting? What were your highlights? Share your thoughts with us via PTEditor@mmhgroup.com
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Psych Consult: TSH Testing in New-Onset Depression. An Endocrinologist’s Guidance for Psychiatrists
2
ADHD Medications for Managing Menopausal Brain Fog: Improvements in Subjective Executive Function
3
What Do Patient-Level Studies Tell Us About Antidepressants and Suicide Risk?
4
New Phase 2 Data on Bezisterim for the Treatment of Long COVID
5